053030 — Binex Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for Binex Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	134,399	156,677	154,825	130,051	168,475
Cost of Revenue
Gross Profit	59,985	70,503	56,948	21,289	45,073
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	121,179	139,498	151,459	160,806	173,010
Operating Profit	13,220	17,179	3,366	-30,755	-4,535
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	24,234	15,234	4,895	-38,927	-5,700
Provision for Income Taxes
Net Income After Taxes	19,030	12,365	4,584	-35,180	-3,289
Minority Interest
Net Income Before Extraordinary Items
Net Income	19,094	12,445	4,671	-35,071	-3,226
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	19,094	12,445	4,671	-35,071	-3,226
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	600	402	57.1	-1,120	-101
Dividends per Share